Skip to content

The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study

The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04083742
Enrollment
59
Registered
2019-09-10
Start date
2019-08-22
Completion date
2023-12-31
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Narrow Angle, Open Angle

Brief summary

This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment metrics with the ANTERION

Interventions

DEVICEANTERION

3 repeat angle measurements performed on each of the 3 Anterion devices and the 3 reference devices

Sponsors

Heidelberg Engineering GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age 22 years or older 2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions 3. Able to fixate 4. With at least one of following eye status for the corresponding eye population: A. Eye with Open Angle (defined by Spaeth gonioscopy grading) B. Eye with Narrow Angle (defined by Spaeth gonioscopy grading)

Exclusion criteria

1. Subjects which were enrolled in the B-2018-1 study 2. Active infection or inflammation in either eye 3. Insufficient tear film or corneal reflex 4. Physical inability to be properly positioned at the study devices or eye exam equipment 5. Rigid contact lens wear during 2 weeks prior to day when study device acquisitions take place 6. Soft lenses worn within one hour prior to study device acquisitions

Design outcomes

Primary

MeasureTime frameDescription
Agreement 61 dayAgreement of AOD parameters \[µm\] between the ANTERION and the reference device
Repeatability and Reproducibility 11 dayReproducibility and repeatability of Spur to Spur distance parameter \[mm\] of ANTERION and the reference device
Repeatability and Reproducibility 21 dayReproducibility and repeatability of Angle to Angle distance parameter \[mm\] of ANTERION and the reference device
Repeatability and Reproducibility 31 dayReproducibility and repeatability of Lens Vault parameter \[µm\] of ANTERION and the reference device
Repeatability and Reproducibility 41 dayReproducibility and repeatability of Anterior Segment Angles parameter \[°\] of ANTERION and the reference device
Repeatability and Reproducibility 51 dayReproducibility and repeatability of TISA parameters \[mm2\] of ANTERION and the reference device
Repeatability and Reproducibility 61 dayReproducibility and repeatability of AOD parameters \[µm\] of ANTERION and the reference device
Agreement 11 dayAgreement of Spur to Spur distance parameter \[mm\] between the ANTERION and the reference device
Agreement 21 dayAgreement of Angle to Angle distance parameter \[mm\] between the ANTERION and the reference device
Agreement 31 dayAgreement of Lens Vault parameter \[µm\] between the ANTERION and the reference device
Agreement 41 dayAgreement of Anterior Segment Angles parameter \[°\] between the ANTERION and the reference device
Agreement 51 dayAgreement of TISA parameters \[mm2\] between the ANTERION and the reference device

Secondary

MeasureTime frameDescription
Adverse Events Rate1 dayAdverse events found during the clinical study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026